Use of drotrecogin alfa (activated) in a severe acute respiratory syndrome patient with severe sepsis

被引:1
|
作者
McRitchie, Donna [1 ]
Farooq, Warda [1 ]
Fisher, Harold N. [2 ]
机构
[1] Univ Toronto, N York Gen Hosp, Toronto, ON, Canada
[2] Eli Lilly Canada Inc, Toronto, ON, Canada
关键词
D O I
10.1155/2008/501759
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
引用
收藏
页码:258 / 259
页数:2
相关论文
共 50 条
  • [1] The use of drotrecogin alfa (activated) in a patient with severe acute respiratory syndrome
    Farooq, W
    McRitchie, D
    CHEST, 2003, 124 (04) : 272S - 272S
  • [2] Drotrecogin alfa (activated) in severe sepsis
    Baillie, JK
    Murray, G
    NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (01): : 95 - 95
  • [3] Drotrecogin alfa (activated) in severe sepsis
    Poole, Daniele
    Rossi, Carlotta
    Addis, Antonio
    Livigni, Sergio
    Bertolini, Guido
    LANCET INFECTIOUS DISEASES, 2013, 13 (02): : 107 - 108
  • [4] Use of drotrecogin alfa (activated) in older patients with severe sepsis
    Alexander, SL
    Ernst, FR
    PHARMACOTHERAPY, 2006, 26 (04): : 533 - 538
  • [5] Introduction: severe sepsis and drotrecogin alfa (activated)
    Artigas, Antonio
    Martin, Claude D.
    CRITICAL CARE, 2007, 11 (Suppl 5)
  • [6] Drotrecogin alfa (activated) in severe sepsis Reply
    Kalil, Andre C.
    LaRosa, Steven P.
    LANCET INFECTIOUS DISEASES, 2013, 13 (02): : 110 - 111
  • [7] Drotrecogin alfa (activated): the treatment for severe sepsis?
    Vincent, Jean-Louis
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2007, 7 (11) : 1763 - 1777
  • [8] Steroids and drotrecogin alfa (activated) for severe sepsis
    Steingrub, JS
    CHEST, 2003, 124 (05) : 2033 - 2033
  • [9] Introduction: severe sepsis and drotrecogin alfa (activated)
    Antonio Artigas
    Claude D Martin
    Critical Care, 11
  • [10] Drotrecogin Alfa (Activated) in the Treatment of Severe Sepsis
    Vincent, Jean-Louis
    CURRENT DRUG SAFETY, 2007, 2 (03) : 227 - 231